How can doctors and the medical community improve care to patients who are diagnosed with Alzheimer’s and Parkinson’s during pre-clinical and clinical stages? Even before new drugs have been approved, early detection is critical in managing – or even reversing – the course of the disease. Meet Amprion and its small group of scientists on a mission to stop Alzheimer’s and Parkinson’s before we lose another generation. Through Amprion’s revolutionary Early Detection Prion Testing, we can help doctors track the biomarkers or prions (aka misfolded proteins) that cause Alzheimer’s and Parkinson’s.
Find out why accurate, early diagnosis of Alzheimer’s and Parkinson’s has been so challenging. Through Amprion’s breakthrough Prion Early Detection Science, we now have a 20/20 vision to track the actual footprint of all three biomarkers or prions that drive the progression of Alzheimer’s and Parkinson’s before the start of any clinical symptoms.
Amprion Help Doctors
The key to effective treatment is early detection. For people with Alzheimer’s and Parkinson’s, this has not been possible. In the past, the only way to tell where someone’s brain is at with respect to neurodegenerative disease is for them to die and look at the brain. That does not allow people to be proactive and preventive.
We allow a very simple test right now from the cerebrospinal fluid. Soon we’ll be able to do this in the blood. People can get real-time feedback as to how their brain is aging. And not everyone’s brain clearly ages at the same rate. Some people develop memory symptoms and motor symptoms as early as their 40’s and 50’s. Others live to be in their 100’s and never show a sign of memory loss or motor problems. We would like to be able to help people navigate their own brain health so that everyone has the ability to push any of these symptoms of brain loss into their 100’s. This is absolutely a problem today.
That the diagnosis today is too late because it happens when people start to develop problems all the brain has already been destroyed. You need, absolutely need, early detection to have a test that can say that you are in the process to develop Alzheimer’s disease or Parkinson’s disease. Pretty much what is done, for example, measuring cholesterol to prevent heart diseases. And we need to intervene with a safe treatment to eliminate the problem.
At Amprion we help people do what we call preventive brain care and quality brain aging. Amprion’s technology allows medical professionals to track the biomarkers that drive the progression of Alzheimer’s and Parkinson’s in their patients. We help doctors help patients.